Dr Shi-Hsiang Shen - Biography

Dr Shi-Hsiang Shen
Tél. : (514) 496-6318
Téléc. : (514) 496-5143
Courriel : shi.shen@cnrc-nrc.gc.ca

Dr. Shi-Hsiang Shen is the group leader of Mammalian Cell Genetics Group at the BRI, National Research Council (NRC) of Canada, since May 1987. He holds a Ph.D. from the Shanghai Institute of Biochemistry at the Chinese Academy of Sciences. Dr. Shen has been an Adjunct Professor at the Faculty of Medicine at McGill University since 1991. Prior to joining the BRI, he was the director of the Genetics Division at the Connaught Research Institute in Toronto for the development of vaccine and related recombinant products. As a distinguished member of an international research program, Dr. Shen was awarded a research grant from the prestigious international Human Frontier Science Program (HFSP) for PTPs research. He has also received a number of other research grants, including CIHR, NSERC and PENCE. Dr. Shen had been a consultant for pharmaceutical companies, such as Pharmacia Italy and Promega, and was a director of R & D for NIM Biomedical Inc., Montreal, through a NRC contract with the company. His areas of research focus mainly on cellular signal transduction through identification and validation of signalling molecular targets and characterization of protein interactions. His lab was the first to discover an important PTP, the SH2 domain-containing PTP, SHP1 and then the second SH2 domain-containing PTP, SHP2; both leading to internationally recognized scientific publications..

To know more about the Mammalian Cell Genetics Group research activities, please visit the Mammalian Cell Genetics Group section on the NRC-BRI web site.